Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Abstract:
Objective: To quantify safety and 6-month effectiveness of non-ablative radiofrequency (RF) on symptoms of pelvic floor dysfunction (PFD) and genitourinary syndrome of menopause (GSM) in women seeking intimate anti-aging.
Methods?Three centres enrolled 208 women (45-65 y) with stage I-II POP, SUI Q≤3, FSFI≤26.5. Three intravaginal mono-polar RF sessions (6 MHz, 41 °C, 20 min) were delivered. Primary outcomes: 1-h pad test, FSFI, ICIQ-UI SF at 1, 3, 6 m. Secondary: Vaginal Health Index (VHI), VLQ, adverse events (CTCAE v5).
Results?Mean pad weight fell from 18.4 g to 5.2 g at 6 m (p<0.001); 72 % achieved ≥50 % reduction. FSFI rose 20.1→27.8 (p<0.001) with 68 % reaching MCID ≥6. ICIQ-UI decreased 9 points; VHI improved 90.9 %/81.9 % at 1/3 m. No grade ≥2 adverse events. RF predicted 3.8-fold higher odds of combined MCID+pad reduction (95 % CI 2.1-6.9) after BMI/parity adjustment.
Conclusions?Non-ablative RF provides rapid, durable improvement of continence and sexual function in early PFD/GSM with excellent safety, supporting its use as a low-risk ambulatory option before invasive surgery
